GRTS News and Press, Gritstone Oncology Inc. From 11/02/23

Acushnet Holdings Corp. (GOLF) is expected to report $0.54 for Q3 2023 Paramount Global (PARA) is expected to report $0.09 for Q3 2023 Curis Inc. (CRIS) is expected to report $-2.32 for Q3 2023 Quanta Services Inc. (PWR) is expected to report $1.99 for Q3 2023 GRI Bio Inc. (GRI) i...

Gritstone bio Inc. (GRTS) is expected to report $-0.34 for Q3 2023

2023-10-14 02:21:03 ET Summary GRTS's COVID-19 vaccine may produce more durable immunity than current mRNA vaccines, according to data from phase 1 studies. GRTS has secured a $433 million contract with BARDA to conduct a phase 2b study comparing its COVID-19 vaccine with an appro...

VANCOUVER, British Columbia and BASEL, Switzerland, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust and expansive lipid nanoparticle (LNP) patent portfolio, today announced the use of its LNP technology in Gritst...

-- High neutralizing antibody (nAb) responses sustained through at least 12 months, highlighting potential for durable clinical protection -- -- T cell responses to Spike plus other viral targets observed in all Phase 1 studies, demonstrating broad and potentially variant-proof immune respo...

2023-10-10 10:00:01 ET More on Health Care Select Sector SPDR Citi turns cautious on pharmaceuticals and biotech BofA Securities: Which small cap non-earner stocks to avoid Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR For further deta...

2023-10-06 13:55:28 ET More on Gritstone bio Gritstone bio (GRTS) Investor Presentation - Slideshow Gritstone: Trying To Pick Itself Up From The COVID Ruins Gritstone shares rally on BARDA contract for new COVID-19 vaccine Seeking Alpha’s Quant Rating ...

2023-10-06 13:29:08 ET Gainers: Falcon's Beyond Global  (FBYD) +145% . American Oncology Network  ( AONC ) +53% . Akso Health Group  ( AHG ) +23% . Vigil Neuroscience  ( VIGL ) +20% . NuScale Power Corporation ( SMR )...

2023-10-06 10:35:53 ET More on Health Care  Sector SPDR September Labor Report Preview: Full Employment To Infinity Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) Citi turns cautious on pharmaceuticals and biotech BofA Securities: ...

EMERYVILLE, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced results from all three (3) Phase 1 studies evaluating its self-amplifying mRNA (samRNA) vacc...